Simulations Plus (NASDAQ:SLP) Price Target Raised to $19.00

Simulations Plus (NASDAQ:SLP) had its target price lifted by TD Cowen from $16.00 to $19.00 in a research report sent to investors on Thursday morning,Benzinga reports. TD Cowen currently has a hold rating on the technology company’s stock.

Other research analysts have also issued research reports about the stock. Citigroup reiterated a “market perform” rating on shares of Simulations Plus in a report on Tuesday. Weiss Ratings restated a “sell (d-)” rating on shares of Simulations Plus in a research report on Wednesday, October 8th. Zacks Research upgraded shares of Simulations Plus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 28th. BTIG Research cut shares of Simulations Plus from a “buy” rating to a “neutral” rating in a research note on Thursday, December 18th. Finally, Cowen reaffirmed a “hold” rating on shares of Simulations Plus in a research report on Thursday. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $25.00.

Simulations Plus Stock Performance

Shares of NASDAQ:SLP opened at $19.60 on Thursday. Simulations Plus has a 52-week low of $12.39 and a 52-week high of $37.67. The company has a market capitalization of $394.84 million, a PE ratio of -6.13 and a beta of 1.09. The company has a fifty day moving average of $18.26 and a 200-day moving average of $16.24.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings data on Thursday, January 8th. The technology company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.05). The firm had revenue of $18.42 million for the quarter, compared to the consensus estimate of $18.05 million. Simulations Plus had a positive return on equity of 13.56% and a negative net margin of 81.66%.During the same quarter in the prior year, the firm earned $0.17 EPS. On average, equities analysts forecast that Simulations Plus will post 1.09 EPS for the current fiscal year.

Institutional Trading of Simulations Plus

Institutional investors have recently bought and sold shares of the company. Royal Bank of Canada raised its position in shares of Simulations Plus by 26.6% in the 1st quarter. Royal Bank of Canada now owns 114,885 shares of the technology company’s stock worth $2,817,000 after acquiring an additional 24,132 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Simulations Plus by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock worth $233,000 after purchasing an additional 390 shares during the period. Dynamic Technology Lab Private Ltd bought a new stake in Simulations Plus in the first quarter worth approximately $255,000. Woodline Partners LP lifted its stake in Simulations Plus by 32.1% in the first quarter. Woodline Partners LP now owns 13,239 shares of the technology company’s stock valued at $325,000 after buying an additional 3,220 shares during the period. Finally, Rhumbline Advisers lifted its stake in Simulations Plus by 2.1% in the first quarter. Rhumbline Advisers now owns 66,222 shares of the technology company’s stock valued at $1,624,000 after buying an additional 1,334 shares during the period. Institutional investors own 78.08% of the company’s stock.

Simulations Plus News Roundup

Here are the key news stories impacting Simulations Plus this week:

• Positive Sentiment: Revenue slightly beat Street expectations and management pointed to strong bookings and services momentum, which supports near‑term revenue visibility and the company’s longer‑term recovery narrative. Business Wire Release
• Positive Sentiment: An analyst at TD Cowen raised the price target (to $19) and maintained a “hold,” a signal that some sell‑side views are stabilizing and may provide support to the stock. Benzinga Note
• Neutral Sentiment: Full earnings call transcripts and slide materials are available for investors who want details on product trends, backlog and guidance assumptions; these give transparency but contain mixed signals. Earnings Call Transcript (Seeking Alpha)
• Neutral Sentiment: Trading volume is elevated versus its average, indicating strong investor interest and greater price sensitivity to news flow. MarketBeat Quote
• Negative Sentiment: The quarter missed consensus EPS ($0.13 vs. $0.18 expected), and software revenue declined ~17% year‑over‑year — the software slowdown is the main headwind to near‑term margins and growth expectations. Investing.com Coverage
• Negative Sentiment: Profitability metrics remain under pressure (reported negative net margin and a weaker EPS vs. prior year), which could limit upside until software trends stabilize or services/AI initiatives convert to consistent earnings growth. Zacks Analysis

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.